To determine the relevance of NCL in breast cancer, we analyzed NCL expression in normal breast tissue, infiltrating ductal carcinoma (IDC) and ductal carcinoma in situ (DCIS) by immunohistochemistry. Here, NUCLEOLIN is linked to breast carcinoma.